Navigation Links
New Avenues to Market - Research Report on Isis Pharmaceuticals, Inc., Avon Products, Inc., Elizabeth Arden, Inc., Boyd Gaming Corporation and Ameristar Casinos, Inc.
Date:2/20/2013

NEW YORK, February 20, 2013 /PRNewswire/ --

Today, National Traders Association announced new research reports highlighting Isis Pharmaceuticals, Inc. (NASDAQ: ISIS), Avon Products, Inc. (NSE: AVP), Elizabeth Arden , Inc. (NASDAQ: RDEN), Boyd Gaming Corporation (NYSE: BYD) and Ameristar Casinos, Inc. (NASDAQ: ASCA). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Isis Pharmaceuticals, Inc. Research Report

Isis is the co-developer of Juxtapid's only competitor Kynamro, which costs less at $176,000 a year. The pill was co-developed by pharmaceutical giant Sanofi, and will be marketing it as soon as possible.

However, the pill wasn't well received by both the FDA and the European Medicines Agency, though it was approved at a 9-6 vote. The EU agency cited cancer risks from the drug. Nevertheless, the drug is expected to sell as much as $400 million, with Isis getting 30 to 50 percent of the profits, depending on the total sales of the drug. Tests conducted by the FDA showed that Juxtapid had lowered bad cholesterol by about half during 26 weeks of study in patients who tolerated the drug, while Kynamro reduced bad cholesterol levels by an average of 25% during the first 26 weeks of treatment. The Full Research Report on Isis Pharmaceuticals, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/entire_report/555f_ISIS]

--

Avon Products, Inc. Research Report

Avon faces several problems as of the moment: they have debt management concerns, their margins are thin, and trends are not working to favor the company's business model.  To turn things around, Avon's new CEO, Sherilyn McCoy , laid out several strategies that are expected to ensure the company's future success. The plan includes reducing its overhead while simultaneously gaining better hold in the markets where it does well, like Asia and Latin America. These plans did not come at a humble price. To implement its strategies, the company had to reduce its dividend by 74 percent. It also plans to lay off 1500 employees in order to meet its plan to save $400 million a year by the end of 2015. Lastly, it will exit the South Korea and Vietnam markets, where it is not particularly growing. But despite these difficult steps, the company is confident that these will help it grow in the long term, making these sacrifices worth their price. The Full Research Report on Avon Products, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/entire_report/6956_AVP]

--

Elizabeth Arden , Inc. Research Report

Meanwhile, Elizabeth Arden grew earnings per share 11% to $1.58, but that was short of estimates at $1.63. Despite the disappointment of investors, the company is confident that it can have a positive momentum by transitioning toward a higher-end brand image. The company is also using the influence of pop starts to its advantage. In North America, sales increased 8.4 percent after adding trendy fragrances to its portfolio like Justin Bieber's Girlfriend, Pink Friday Nicki Minaj and Taylor Swift Wonderstruck Enchanted. By grabbing the opportunities being presented by these partnerships and by rebranding their products, the company has solid plans for future growth. The Full Research Report on Elizabeth Arden , Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/entire_report/748a_RDEN]

--

Boyd Gaming Corporation Research Report

Boyd Gaming generated $117.5 million cash last year. However, cash outflows like major capital expenditures took a toll on their earnings. The company also cites the unpredictability of their revenues, causing them to lay off an uncertain number of employees in various parts of the country including Las Vegas. But things are far from bleak for the company. They recently finished the renovating the Kansas Star Casino, a key element of their recently concluded $1.45 billion acquisition of Peninsula Gaming LLC. The casino will provide the company a platform to access the Kansas market. Besides giving the company more diversity, another reason to conclude that the acquisition will be highly profitable is the property's recent performance. It generated a total of $173.4 million in gambling revenue from late December 2011 to November 2012, and Boyd Gaming CEO Smith expects it to provide even more revenue for the company in the future. The Full Research Report on Boyd Gaming Corporation - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/entire_report/8ca5_BYD]

--

Ameristar Casinos, Inc. Research Report

Ameristar Casinos. Pinnacle had agreed to acquire Ameristar for $869 million in cash or $26.50 per share. However, some investors feel that the transaction may undervalue the company, mainly due to the fact that Ameristar will soon open its 500 million Lake Charles, LA project in 2014. Furthermore, analysts set a high target price for Ameristar, some even going as high as $33.00 per share.

Ameristar plans to release its fourth quarter 2012 financial results on the week of February 4, 2013. This is going to give us further insight as to how fair its recent deal is. But Ameristar's board is optimistic about agreeing to Pinnacle's terms, saying that the increased scale and diversification of the company will expand opportunities and provide enhancements for guests. Now is not the time for traditional casino and gaming companies like Boyd Gaming and Ameristar to relax because of impending competition from internet gambling. Nevada will lead the way as online poker gets underway there in 2013, and the comprehensive regulatory scheme developed there can serve as a model for other states considering the legalization of online gambling. The Full Research Report on Ameristar Casinos, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at: [http://www.nationaltradersassociation.org/r/entire_report/f2d2_ASCA]

--

Consider National Traders Association

Tired of hearing about the latest, greatest trade opportunity... only to realize that the ship has long sailed? You need a strong, informative community in your arsenal. Join the group that has been consistently identifying momentous situations as they develop - long before they become the next top news on major financial networks.

Contact:
Demi Lapierre
Email: press@NationalTradersAssociation.org
Main: +1(702)212-4493


'/>"/>
SOURCE National Traders Association
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Global Radiopharmaceuticals Market Is Expected to Reach USD 12.2 Billion in 2018: Transparency Market Research
2. Revenue Growth Optimism in Pharmaceutical Industry: 2013 Survey Reports at RnRMarketResearch.com
3. Analysis of the U.S. Neurostimulation Market
4. The Annual Managed Markets Summit Opens Next Week In Miami
5. HYCOR Divests Urinalysis Business to Increase Focus on Allergy and Autoimmune Markets
6. Abaxis to Present at Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference
7. Gro-International to Develop BioElectronics OTC Brands in European and African Markets
8. European Diagnostic Imaging System Market Will Grow Modestly To Almost $2.2 Billion In 2017
9. The Medical Device Market: Russia
10. Physicians Adoption of Velcade for the Treatment of Chronic Graft Versus Host Disease Will Drive Growth In This Market Through 2021
11. Cognizant Recognized as a Leader in Life Science Drug Safety Services in IDC MarketScape
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... , May 24, 2016  Joe Marziani has joined VMS BioMarketing as senior vice ... officer, today. In his new role, Marziani will lead the company,s business development and ... to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
(Date:5/24/2016)... May 24, 2016 ... , la première endoprothèse à double ... à l,intervention portant sur les membres inférieurs ... OrbusNeich, entreprise mondiale spécialisée dans la ... la vie, a élargi son portefeuille pour ...
(Date:5/24/2016)... May 24, 2016 Een app ... zodat zij collectief patiënten kunnen behandelen, hun kennis kunnen ... idee achter de nieuwe en revolutionaire MDLinking App, ontwikkeld ... Nederlandse vaatchirurg dr. Hans Flu en oncologisch chirurg dr. ... inmiddels beschikbaar is, wordt op dinsdag 24 mei officieel ...
Breaking Medicine Technology:
(Date:5/26/2016)... , ... May 26, 2016 , ... W.S. Badger ... has been honored with a 2016 When Work Works Award for its use of ... of the national When Work Works project administered by the Families and Work Institute ...
(Date:5/26/2016)... , ... May 26, 2016 , ... On Memorial Day, ... women who lost their lives in military battle for the country. The nonprofit ... 2015 to provide more programs that empower independence for disabled military veterans, as well ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... solutions for drugs, biologics, consumer health and global clinical supply services, today announced ... to support the company’s continued investment and strategic growth plans in the Asia ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of ... today announced the organization has earned its ISO 13485 certification, indicating the company’s ... with all rules and policies associated with ISO quality standard 13485. , ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... and chief medical officer of Blue Horizon International (BHI), Brian Mehling, M.D., spoke ... was held during May 5-6, 2016 in Chicago, IL, USA. Dr. Mehling’s presentation ...
Breaking Medicine News(10 mins):